The vanishing importance of age in renal transplantation.

BACKGROUND The growing number of patients awaiting a kidney transplant raises questions about allocation of kidneys to the elderly and about the use of elderly donors. In all reported studies analyzing the influence of age on the outcome after renal transplantation, age is investigated as a categorical variable. METHODS We studied age both as a categorical (Kaplan-Meier) and as a continuous (Cox) variable in a total of 509 cyclosporine-treated recipients of a primary cadaveric kidney graft who underwent transplantation between July 1983 and July 1997. For the Kaplan-Meier analysis, the population was divided into three comparably sized age groups: 17-43 years (n=171), 44-55 years (n=169), and 56-75 years (n=169). RESULTS Patient survival was better and graft survival censored for death was worse in the younger patients. Overall graft survival (end point was death or graft failure) was not significantly influenced by age. In the Cox proportional hazards analysis, transplantation year turned out to be an important, independent variable influencing all end points. Because the influence was not linear, three periods were defined in which the relative risk remained stable: 1983-1990, 1991-1993, and 1994-1997. In the second period, the relative risk for transplant failure or death was 49% of that in the first period. In the third period, the relative risk had decreased to 22% of that in the first period. Recipient age and donor age were significant predictors of overall transplant failure. There was no interaction between these variables and transplantation year. Within each transplantation period, an increase in recipient age by 1 year increased the relative risk for overall graft failure by only 1.44%. The influence of donor age followed a J-shaped curve with a minimum at 30 years. The influence of increasing either recipient or donor age was counteracted by the improving results over time. CONCLUSION Considering the improving results over time, there are, at this moment, no arguments for an age restriction for kidney transplant recipients or donors.

[1]  M. Henry,et al.  Renal transplantation in older people , 1994, The Lancet.

[2]  D. Serón,et al.  Renal transplantation in cyclosporine-treated patients over age 50. , 1992, Transplantation proceedings.

[3]  R. Velez,et al.  Renal transplantation with cyclosporine in the elderly population. , 1991, Transplantation proceedings.

[4]  N. Holbrook,et al.  Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. , 1989, Clinical immunology and immunopathology.

[5]  P. Morris,et al.  Renal transplantation in the older patient. , 1989, Transplantation proceedings.

[6]  R. Fennell,et al.  Kidney transplantation in older patients. , 1989, Transplantation proceedings.

[7]  C. Groth,et al.  Recipient age--an important factor for the outcome of cadaver renal transplantation in patients treated with cyclosporine. , 1989, Transplantation proceedings.

[8]  C. Groth,et al.  Kidney transplantation in patients between 65 and 75 years of age. , 1989, Transplantation proceedings.

[9]  J. Alexander,et al.  Current experience with renal transplantation in older patients. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  A. Ting,et al.  Renal transplantation in patients over 55 years old , 1988, The British journal of surgery.

[11]  P. Weiner,et al.  Decline in mitogen induced proliferation of lymphocytes with increasing age. , 1987, Clinical and experimental immunology.

[12]  A. Novick,et al.  Renal transplantation in the older recipient. , 1985, The Journal of urology.

[13]  C. Rudge,et al.  Successful treatment of middle aged and elderly patients with end stage renal disease. , 1983, British medical journal.

[14]  B. Lindholm,et al.  Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapy. , 1982, Transplantation proceedings.

[15]  M. Weksler,et al.  Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. , 1981, The Journal of clinical investigation.

[16]  F. Berthoux,et al.  Transplantation Report. 1: renal transplantation in recipients aged 60 years or older at time of grafting. The EDTA-ERA Registry. European Dialysis and transplant Association-European Renal Association. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  A. Fietta,et al.  Influence of aging on some specific and nonspecific mechanisms of the host defense system in 146 healthy subjects. , 1994, Gerontology.

[18]  J. Soulillou,et al.  Cadaveric renal transplantation after 60 years of age , 1994, Transplant international : official journal of the European Society for Organ Transplantation.

[19]  C. Caruso,et al.  gamma-Interferon, interleukin-4 and interleukin-6 in vitro production in old subjects. , 1993, Autoimmunity.

[20]  F. Oppenheimer,et al.  Renal transplantation in elderly recipients : IInd congress of the Catalan Transplantation Society, Barcelona, Spain, February 18-20, 1991 , 1992 .

[21]  R. Calne,et al.  Cadaveric renal transplantation in elderly recipients: is it worthwhile? , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  J. Morales,et al.  Renal transplantation in elderly recipients. , 1989 .